Taking your unique needs and treatment goals into account, well determine the medication and dosage thats right for you
I hate products that have that artificially sweet scent (as I call it) like in facial creams but I do appreciate natural scents & this one has my seal of approval
Weight interventions improve PsA outcomes PsA treatment guidelines support obesity management in patients with active PsA and obesity GRAPPA recommends maintenance of a healthy weight to improve disease activity and minimize disease impact 8 ACR recommends weight loss for patients with overweight/obesity 15 EULAR recommends that comorbidities such as obesity, metabolic syndrome, cardiovascular disease or depression should be considered managing patients with PsA 16 The modalities of weight management include lifestyle modification (nutrition, physical activity, psychological and behavioral intervention), pharmacotherapy, and bariatric surgery 17-20 Diet-based weight reduction is associated with achievement of MDA in patients with PsA and overweight/obesity starting TNFi therapy 6 5% weight reduction is the major and independent predictor of achieving MDA 6 Odds of achieving MDA increase with higher percent of weight reduction 6 In the DIPSA trial, weight loss magnitude was significantly associated with improvement in clinical outcomes, including DAPSA, pain, fatigue, PsAID, and TJC
Im not sure why there isnt a warning [for gastroparesis] yet. (During the September presentation of scientific evidence, representatives for Novo Nordisk noted that Etminan and his co-authors are not gastroenterologists and said their study was not enough to establish cause and effect.) Eli Lillys warning label for Mounjaro says it can cause severe gastrointestinal problems and is not recommended for patients with preexisting gastroparesis, but the label doesnt explicitly list gastroparesis as a possible side effect
(2014) has shown that IGF-1R is one of direct targets of miR-99a in OSCC, which has been reported in several studies to be downregulated in clinical samples of OSCC in different stages (Yan et al., 2012)
